Evidence map›Paper›PMID 37947674›Full record

ArticleNanomaterials (Basel, Switzerland)2023

Zeolitic Imidazolate Frameworks Serve as an Interface Layer for Designing Bifunctional Bone Scaffolds with Antibacterial and Osteogenic Performance.

Jingxi Huang, Chen Cheng, Youwen Yang, Jun Zan, Cijun Shuai

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Jingxi HuangInstitute of Additive Manufacturing, Jiangxi University of Science and Technology, Nanchang 330013, China.
Chen ChengInstitute of Additive Manufacturing, Jiangxi University of Science and Technology, Nanchang 330013, China.
Youwen YangInstitute of Additive Manufacturing, Jiangxi University of Science and Technology, Nanchang 330013, China.ORCID 0000-0003-1557-0252
Jun ZanInstitute of Additive Manufacturing, Jiangxi University of Science and Technology, Nanchang 330013, China.
Cijun ShuaiInstitute of Additive Manufacturing, Jiangxi University of Science and Technology, Nanchang 330013, China.
Jiangxi University of Science and Technology · CNCentral South University · CNHong Kong Polytechnic University · HK

Funding

National Natural Science Foundation of China 51935014, 52165043, 52105352, 82072084
6 · The paper itself

Abstract

The integration of hydroxyapatite (HA) with broad-spectrum bactericidal nano-silver within biopolymer-based bone scaffolds not only promotes new bone growth, but also effectively prevents bacterial infections. However, there are problems such as a poor interface compatibility and easy agglomeration. In this project, zeolitic imidazolate frameworks (ZIF-8) were grown in situ on nano-HA to construct a core-shell structure, and silver was loaded into the ZIF-8 shell through ion exchange. Finally, the core-shell structure (HA@Ag) was composited with polylactic acid (PLLA) to prepare bone scaffolds. In this case, the metal zinc ions of ZIF-8 could form ionic bonds with the phosphate groups of HA by replacing calcium ions, and the imidazole ligands of ZIF-8 could form hydrogen bonds with the carboxyl groups of the PLLA, thus enhancing the interface compatibility between the biopolymers and ceramics. Additionally, the frame structure of MOFs enabled controlling the release of silver ions to achieve a long-term antibacterial performance. The test results showed that the HA@Ag nanoparticles endowed the scaffold with good antibacterial and osteogenic activity. Significantly, the HA@Ag naoaprticle exhibited a good interfacial compatibility with the PLLA matrix and could be relatively evenly dispersed within the matrix. Moreover, the HA@ZIF-8 also effectively enhanced the mechanical strength and degradation rate of the PLLA scaffold.

Indexed as

antibacterial activitybone scaffoldosteogenic performancepolylactic acid (PLLA)zeolitic imidazolate frameworks (ZIF-8)

Identifiers

PMID37947674
PMCPMC10647501
OpenAlexW4388267472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.